Steven Tisseverasinghe
Papers
1
Total Citations
2
H-Index
1
About
Dr. Steven Tisseverasinghe is a rising authority in the intersection of nuclear medicine and urologic oncology, with a particular focus on prostate cancer. His work centers on the clinical application of advanced molecular imaging, specifically Prostate-Specific Membrane Antigen (PSMA)-targeted PET/CT, to improve the detection and management of recurrent and metastatic disease. In his notable 2023 case report, Dr. Tisseverasinghe documented an exceedingly rare instance of port-site metastasis identified on 18F-DCFPyL PET/CT following robot-assisted laparoscopic radical prostatectomy. This contribution is critical, as it highlights the superior sensitivity of PSMA imaging in uncovering atypical recurrence patterns that conventional scans might miss, thereby informing more precise salvage treatment strategies. While his most-cited paper currently holds 2 citations, its clinical significance lies in raising awareness among surgeons and oncologists about this uncommon complication. Dr. Tisseverasinghe’s research is helping to refine post-prostatectomy surveillance protocols and underscores the transformative role of theranostics in personalizing prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1